Retatrutide – 10 mg
Retatrutide – 10 mg Retatrutide 10mg refers to the highest maintenance dose of this investigational triple-agonist drug (targeting GLP-1, GIP, and glucagon receptors) used for significant weight loss and blood sugar control in Type 2 diabetes, administered as a weekly injection, with the 10mg dose typically reached after a gradual titration period and showing powerful weight reduction results in trials, though it carries common GI side effects like nausea and diarrhea.
Research Use Only Disclaimer
FOR RESEARCH USE ONLY This product is not intended for human or animal use.Not for medical, diagnostic, therapeutic, metabolic, endocrine, or consumption purposes.No dosage, administration, or biological outcome claims are made or implied.Use is restricted to qualified laboratory research environments only.
❓Frequently Asked Questions
Is retatrutide approved for weight loss or metabolic use?
No. This peptide is supplied strictly for laboratory research purposes.
Does this product include a Certificate of Analysis (COA)?
Yes. Every batch includes a third-party verified COA.
Why is retatrutide supplied in a 10 mg research format?
This quantity supports analytical testing, stability studies, and reference evaluation, not application or use.
Can this compound be used in humans or animals?
No. It is not approved for use in living systems.
How is this product classified?
It is classified solely as a research peptide, not a drug, supplement, or therapeutic agent.